Changes in Use of Lipid-lowering Medications Among Black and White Dual Enrollees With Diabetes Transitioning From Medicaid to Medicare Part D Drug Coverage-Reference-Cited by-同舟云学术

Changes in Use of Lipid-lowering Medications Among Black and White Dual Enrollees With Diabetes Transitioning From Medicaid to Medicare Part D Drug Coverage

Published:2014-08 Issue:8 Volume:52 Page:695-703
ISSN:0025-7079
Container-title:Medical Care
language:en
Short-container-title:

Author:

Adams Alyce S.,Madden Jeanne M.,Zhang Fang,Soumerai Stephen B.,Gilden Dan,Griggs Jennifer,Trinacty Connie M.,Bishop Christine,Ross-Degnan Dennis

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Public Health, Environmental and Occupational Health

Reference4 articles.

1. Racial disparities in prescription drug use among dually eligible beneficiaries.;Schore;Health Care Financ Rev,2003

2. The impact of implementing a more restrictive prescription limit on Medicaid recipients: effect on cost, therapy and out-of-pocket expenditures.;Martin;Med Care,1996

3. Impact of Medicare Part D on Medicare-Medicaid dual-eligible beneficiaries prescription utilization and expenditures.;Basu;Health Serv Res,2010

4. Under the shadow of Tuskegee: African Americans and health care.;Gamble;Am J Public Health,1997

Cited by 15 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Effect of motivated physicians and elderly patients with hypertension or type 2 diabetes mellitus in prepared communities on health behaviours and outcomes: A population-based PS matched retrospective cohort study during five-year follow-up period;PLOS ONE;2024-02-13

2. The Impact of Prescription Drug Coverage on Disparities in Adherence and Medication Use: A Systematic Review;Medical Care Research and Review;2024-01-04

3. Barriers and Facilitators in Access to Diabetes, Hypertension, and Dyslipidemia Medicines: A Scoping Review;Public Health Reviews;2022-09-02

4. Pharmaceutical policies: effects of regulating drug insurance schemes;Cochrane Database of Systematic Reviews;2022-05-03

5. The role of integrated medical and prescription drug plans in addressing racial and ethnic disparities in medication adherence;Journal of Managed Care & Specialty Pharmacy;2022-03